<?xml version="1.0" encoding="UTF-8"?>
<ref id="B93-pharmaceuticals-12-00147">
 <label>93.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Götz</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Magar</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Dornfeld</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Giese</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Pohlmann</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Höper</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Kong</surname>
    <given-names>B.-W.</given-names>
   </name>
   <name>
    <surname>Jans</surname>
    <given-names>D.A.</given-names>
   </name>
   <name>
    <surname>Beer</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Haller</surname>
    <given-names>O.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import</article-title>
  <source>Sci. Rep.</source>
  <year>2016</year>
  <volume>6</volume>
  <fpage>23138</fpage>
  <pub-id pub-id-type="doi">10.1038/srep23138</pub-id>
  <pub-id pub-id-type="pmid">26988202</pub-id>
 </element-citation>
</ref>
